Grn163l Completed Phase 2 Trials for Myeloid Malignancy / Secondary Myelofibrosis / Primary Myelofibrosis (PMF) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01731951Imetelstat Sodium in Treating Participants With Primary or Secondary Myelofibrosis